All articles by Sofia Karadima

Sofia Karadima is a senior editor and researcher at Investment Monitor, focusing on financial and business services, and ESG investing. She previously covered institutional investment across private markets for financial news and research provider Acuris. She has reported on private equity, venture capital, private debt and infrastructure, among other topics. Sofia is currently based in London, after living in Chile, Denmark, Spain and Greece.

Sofia Karadima

FDI in pharmaceuticals in 2021: The state of play

Pharmaceuticals FDI fell by 17.3% in 2021 as the sector continues to experience a slow recovery from the Covid-19 pandemic.

Foreign investments amplify the nucleic acid therapeutics field

FDI in the nucleic acid therapeutics field grew by 52% in 2021, recording a strong increase since the pandemic slowdown.

FDI drivers in 2022: ESG

The global race to net zero has turned ESG into one of the most important drivers of FDI in the post-Covid world.

FDI in pharmaceuticals: The state of play

The pharmaceutical industry suffered a dip in FDI in 2020 as the Covid-19 pandemic hit, but did any countries manage to avoid this drop?

Holistic thinking is prescribed for investors on World Health Day 2022

World Health Day 2022 offers investors the opportunity to think beyond the laboratories and consider the impact their healthcare activities can have.

An ethical dilemma: Should companies still sell essential products in Russia?

Is it ethical to sell baby food in Russia in an era of sanctions? Or medicine? This is a dilemma many Western companies are facing, with few easy answers.